These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11979)

  • 1. Metabolism of methoxyphenamine in man and in monkey.
    Midha KK; Cooper JK; Mcgilveray IJ; Coutts RT; Dawe R
    Drug Metab Dispos; 1976; 4(6):568-76. PubMed ID: 11979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey.
    Midha KK; Hubbard JW; Bailey K; Cooper JK
    Drug Metab Dispos; 1978; 6(6):623-30. PubMed ID: 33023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human metabolism of cyproheptadine.
    Porter CC; Arison BH; Gruber VF; Titus DC; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(3):189-97. PubMed ID: 238818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation products of 3,4,4'-trichlorocarbanilide in rat, monkey, and man.
    Birch CG; Hiles RA; Eichhold TH; Jeffcoat AR; Handy RW; Hill JM; Willis SL; Hess TR; Wall ME
    Drug Metab Dispos; 1978; 6(2):169-76. PubMed ID: 26533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of p-methoxyamphetamine in dog and monkey. O-demethylation as a major route.
    Hubbard JW; Midha KK; Cooper JK
    Drug Metab Dispos; 1977; 5(4):329-34. PubMed ID: 19212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-O-methyl-alpha-methyldopamine, a urinary metabolite of p-methoxyamphetamine in dog and monkey.
    Hubbard JW; Bailey K; Midha KK; Cooper JK
    Drug Metab Dispos; 1981; 9(3):250-4. PubMed ID: 6113935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry.
    Lynn RK; Bauer JE; Gordon WP; Smith RG; Griffin D; Thompson RM; Jenkins R; Gerber N
    Drug Metab Dispos; 1979; 7(3):138-44. PubMed ID: 38083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective in vivo inhibition by quinidine of methoxyphenamine oxidation in rat models of human debrisoquine polymorphism.
    Muralidharan G; Midha KK; McKay G; Hawes EM; Inaba T
    Xenobiotica; 1989 Feb; 19(2):189-97. PubMed ID: 2786289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of new secondary metabolites of methoxyphenamine in man.
    McKay G; Cooper JK; Hawes EM; Roy SD; Midha KK
    Xenobiotica; 1983 Apr; 13(4):257-64. PubMed ID: 6624141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of metabolites of methoxyphenamine in man [proceedings].
    McGilveray IJ; Midha KK; Cooper JK; Coutts RT; Dawe R
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():55P. PubMed ID: 12332
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
    Midha KK; Cooper JK; By A; Ethier JC
    Drug Metab Dispos; 1977; 5(2):143-8. PubMed ID: 15806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of glucuronide metabolites of carbamazepine in human urine by gas chromatography and mass spectrometry.
    Lynn RK; Smith RG; Thompson RM; Deinzer ML; Griffin D; Gerber N
    Drug Metab Dispos; 1978; 6(4):494-501. PubMed ID: 28932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative metabolism of zolazepam in rat, dog and monkey.
    Baukema J; Okerholm RA; Glazko AJ
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):227-38. PubMed ID: 808840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of dimethylamphetamine in rat and man.
    Inoue T; Suzuki S
    Xenobiotica; 1987 Aug; 17(8):965-71. PubMed ID: 3673111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man.
    Hucker HB; Stauffer SC; Balletto AJ; White SD; Zacchei AG; Arison BH
    Drug Metab Dispos; 1978; 6(6):659-72. PubMed ID: 33029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic O-demethylation of 3,4-dimethoxyamphetamine in vivo in dog and monkey.
    Midha KK; Bailey K; Cooper JK; Hubbard JW
    Xenobiotica; 1979 Aug; 9(8):485-90. PubMed ID: 117645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Ewald AH; Fritschi G; Bork WR; Maurer HH
    J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of [14C]-brotizolam in the rat, dog, monkey and man.
    Bechtel WD; Mierau J; Brandt K; Förster HJ; Pook KH
    Arzneimittelforschung; 1986 Mar; 36(3A):578-86. PubMed ID: 3718581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.